KBI Biopharma Announces Subcontract with Mapp on Sudan ebolavirus Treatment
23 Jan 2023 //
BUSINESSWIRE
Avid to Develop Mapp Biopharmaceutical’s Antiviral Drug Candidate in Clinical
26 Aug 2020 //
PHARMATECH
23 Jan 2023 //
BUSINESSWIRE
26 Aug 2020 //
PHARMATECH